Hims & Hers to Announce Q2 2025 Financial Results on August 4, 2025
ByAinvest
Tuesday, Jul 15, 2025 11:12 am ET1min read
HIMS--
In addition to the financial results announcement, Hims & Hers has also announced that members of its management team will be participating in Canaccord Genuity’s 45th Annual Growth Conference on August 13, 2025, in Boston. This conference is expected to provide investors with further insights into the company's strategic plans and future prospects [2].
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. The company provides access to personalized care designed for results, normalizing health and wellness challenges and innovating on their solutions [3].
Investors are advised to stay tuned for the financial results announcement and the conference call for updates on the company's performance. Additionally, shareholders are reminded of the class action lawsuit filed against Hims & Hers, with a deadline to join the class action on August 25, 2025 [1].
References:
[1] https://www.morningstar.com/news/pr-newswire/20250714ny28897/class-action-filed-against-hims-hers-health-inc-hims-august-25-2025-deadline-to-join-contact-the-gross-law-firm
[2] https://investors.hims.com/news/news-details/2025/Hims--Hers-to-Announce-Second-Quarter-2025-Financial-Results-on-August-4-2025/default.aspx
[3] https://www.marketscreener.com/quote/stock/HIMS-HERS-HEALTH-INC-65220697/news/Hims-Hers-to-Announce-Second-Quarter-2025-Financial-Results-on-August-4-2025-50504829/
MORN--
Hims & Hers Health will announce Q2 2025 financial results on August 4, 2025, after market close. The company will host a conference call at 5:00 p.m. ET to discuss the results. Hims & Hers will also participate in Canaccord Genuity's 45th Annual Growth Conference on August 13, 2025, in Boston.
Hims & Hers Health, Inc. (NYSE: HIMS) has announced that it will report its second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year [2].In addition to the financial results announcement, Hims & Hers has also announced that members of its management team will be participating in Canaccord Genuity’s 45th Annual Growth Conference on August 13, 2025, in Boston. This conference is expected to provide investors with further insights into the company's strategic plans and future prospects [2].
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. The company provides access to personalized care designed for results, normalizing health and wellness challenges and innovating on their solutions [3].
Investors are advised to stay tuned for the financial results announcement and the conference call for updates on the company's performance. Additionally, shareholders are reminded of the class action lawsuit filed against Hims & Hers, with a deadline to join the class action on August 25, 2025 [1].
References:
[1] https://www.morningstar.com/news/pr-newswire/20250714ny28897/class-action-filed-against-hims-hers-health-inc-hims-august-25-2025-deadline-to-join-contact-the-gross-law-firm
[2] https://investors.hims.com/news/news-details/2025/Hims--Hers-to-Announce-Second-Quarter-2025-Financial-Results-on-August-4-2025/default.aspx
[3] https://www.marketscreener.com/quote/stock/HIMS-HERS-HEALTH-INC-65220697/news/Hims-Hers-to-Announce-Second-Quarter-2025-Financial-Results-on-August-4-2025-50504829/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet